GENEVA, Jan 22 (Reuters) – The World Health Organization
will begin considering China’s two COVID-19 vaccines for
emergency approval next week, WHO Assistant Director-General
Mariangela Simao said on Friday.
China is promoting two vaccines, made by Sinopharm
and Sinovac, and has signed deals to export millions of
doses of both of them. Simao said the WHO was also looking into
providing emergency approval for AstraZeneca’s vaccine
from manufacturing sites in South Korea and India.
© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters
or its third party content providers. Any copying, republication or redistribution of Reuters content, including
by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon.
"Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.